CTI BioPharma Current Ratio 2006-2020 | CTIC

CTI BioPharma current ratio from 2006 to 2020. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
CTI BioPharma Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2020-03-31 $0.08B $0.01B 5.74
2019-12-31 $0.04B $0.02B 1.92
2019-09-30 $0.05B $0.03B 1.78
2019-06-30 $0.06B $0.02B 3.15
2019-03-31 $0.07B $0.02B 4.04
2018-12-31 $0.08B $0.02B 3.58
2018-09-30 $0.08B $0.02B 3.58
2018-06-30 $0.10B $0.02B 4.28
2018-03-31 $0.11B $0.02B 5.32
2017-12-31 $0.05B $0.02B 2.44
2017-09-30 $0.06B $0.03B 2.19
2017-06-30 $0.08B $0.04B 2.15
2017-03-31 $0.04B $0.04B 0.88
2016-12-31 $0.06B $0.04B 1.37
2016-09-30 $0.07B $0.05B 1.47
2016-06-30 $0.09B $0.04B 2.18
2016-03-31 $0.11B $0.05B 2.46
2015-12-31 $0.14B $0.07B 1.86
2015-09-30 $0.05B $0.04B 1.46
2015-06-30 $0.06B $0.03B 1.93
2015-03-31 $0.05B $0.04B 1.51
2014-12-31 $0.08B $0.04B 2.22
2014-09-30 $0.06B $0.03B 1.94
2014-06-30 $0.04B $0.02B 1.78
2014-03-31 $0.06B $0.02B 3.31
2013-12-31 $0.08B $0.02B 4.01
2013-09-30 $0.03B $0.02B 1.64
2013-06-30 $0.04B $0.02B 1.58
2013-03-31 $0.05B $0.02B 2.39
2012-12-31 $0.06B $0.02B 2.66
2012-09-30 $0.02B $0.03B 0.74
2012-06-30 $0.02B $0.03B 0.65
2012-03-31 $0.03B $0.02B 2.13
2011-12-31 $0.05B $0.02B 2.87
2011-09-30 $0.05B $0.03B 1.62
2011-06-30 $0.04B $0.04B 1.16
2011-03-31 $0.05B $0.04B 1.22
2010-12-31 $0.03B $0.04B 0.66
2010-09-30 $0.02B $0.03B 0.78
2010-06-30 $0.07B $0.07B 1.05
2010-03-31 $0.05B $0.06B 0.76
2009-12-31 $0.04B $0.06B 0.66
2009-09-30 $0.06B $0.07B 0.82
2009-06-30 $0.02B $0.03B 0.49
2009-03-31 $0.01B $0.04B 0.38
2008-12-31 $0.03B $0.04B 0.67
2008-09-30 $0.05B $0.04B 1.19
2008-06-30 $0.05B $0.05B 0.94
2008-03-31 $0.03B $0.05B 0.58
2007-12-31 $0.02B $0.05B 0.42
2007-09-30 $0.05B $0.08B 0.59
2007-06-30 $0.05B $0.08B 0.72
2007-03-31 $0.06B $0.03B 1.72
2006-12-31 $0.07B $0.03B 1.88
2006-09-30 $0.08B $0.03B 2.49
2006-06-30 $0.06B $0.02B 2.77
2006-03-31 $0.06B $0.03B 2.02
2005-12-31 $0.11B $0.03B 3.48
2005-09-30 $0.06B $0.06B 0.91
2005-06-30 $0.05B $0.05B 0.94
2005-03-31 $0.09B $0.03B 2.92
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.076B $0.003B
CTI BioPharma Corp. is a biopharmaceutical company. It is focused on the acquisition, development and commercialization of therapies covering a spectrum of blood-related cancers. The company is heavily focused on marketing its approved therapy Pixuvri in Europe, and on continuing the development of its late-stage development pipeline, including pacritinib. CTI BioPharma Corp., formerly known as Cell Therapeutics, Inc., is headquartered in Seattle, Washington.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $65.594B 37.23
Takeda Pharmaceutical (TAK) Japan $60.596B 10.62
Astellas Pharma (ALPMY) Japan $32.790B 16.38
Eisai (ESALY) Japan $22.308B 41.56
UCB SA (UCBJF) Belgium $17.894B 0.00
Merck (MKGAF) Germany $14.993B 19.66
Grifols, S.A (GRFS) Spain $12.898B 16.03
Catalent (CTLT) United States $11.912B 46.05
Neurocrine Biosciences (NBIX) United States $11.164B 51.60
Ionis Pharmaceuticals (IONS) United States $7.863B 41.81
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.573B 0.00
Orion OYJ (ORINY) Finland $7.459B 33.42
Jazz Pharmaceuticals (JAZZ) Ireland $6.573B 10.52
United Therapeutics (UTHR) United States $5.061B 9.59
Evotec AG (EVTCY) Germany $4.045B 65.24
Nektar Therapeutics (NKTR) United States $3.953B 0.00
ChemoCentryx (CCXI) United States $3.735B 0.00
Hypermarcas (HYPMY) Brazil $3.692B 11.23
Arrowhead Pharmaceuticals (ARWR) United States $3.368B 367.67
FibroGen (FGEN) United States $3.180B 0.00
PTC Therapeutics (PTCT) United States $3.137B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.642B 10.86
Sage Therapeutics (SAGE) United States $1.941B 0.00
Pacira BioSciences (PCRX) United States $1.875B 38.37
USANA Health Sciences (USNA) United States $1.768B 18.13
Xencor (XNCR) United States $1.767B 0.00
Corcept Therapeutics (CORT) United States $1.747B 17.32
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.726B 0.00
Heron Therapeutics (HRTX) United States $1.670B 0.00
Zogenix (ZGNX) United States $1.605B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.575B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.555B 11.90
Akebia Therapeutics (AKBA) United States $1.499B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.449B 15.61
Portola Pharmaceuticals (PTLA) United States $1.401B 0.00
Karyopharm Therapeutics (KPTI) United States $1.375B 0.00
Tilray (TLRY) Canada $1.295B 0.00
Translate Bio (TBIO) United States $1.273B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.224B 0.00
Esperion Therapeutics (ESPR) United States $1.131B 0.00
Indivior (INVVY) United States $1.069B 13.27
Enanta Pharmaceuticals (ENTA) United States $1.032B 46.07
Endo (ENDP) Ireland $0.898B 1.39
ImmunoGen (IMGN) United States $0.837B 0.00
Collegium Pharmaceutical (COLL) United States $0.796B 0.00
Molecular Templates (MTEM) United States $0.705B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.694B 0.00
Aerie Pharmaceuticals (AERI) United States $0.661B 0.00
Ardelyx (ARDX) United States $0.640B 0.00
Radius Health (RDUS) United States $0.618B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.542B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.538B 0.00
Harpoon Therapeutics (HARP) United States $0.515B 0.00
Siga Technologies (SIGA) United States $0.493B 0.00
Innate Pharma SA (IPHYF) France $0.489B 0.00
Organogenesis Holdings (ORGO) United States $0.489B 0.00
Trillium Therapeutics (TRIL) Canada $0.477B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.467B 18.26
DURECT (DRRX) United States $0.467B 0.00
Flexion Therapeutics (FLXN) United States $0.449B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.446B 10.77
Calithera Biosciences (CALA) United States $0.409B 0.00
Ocular Therapeutix (OCUL) United States $0.376B 0.00
MEI Pharma (MEIP) United States $0.350B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.346B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.342B 0.00
TherapeuticsMD (TXMD) United States $0.318B 0.00
Concert Pharmaceuticals (CNCE) United States $0.305B 0.00
Lannett Co Inc (LCI) United States $0.303B 6.64
Avadel Pharmaceuticals (AVDL) Ireland $0.298B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.288B 0.00
CASI Pharmaceuticals (CASI) United States $0.272B 0.00
Rafael Holdings (RFL) United States $0.257B 0.00
Redhill Biopharma (RDHL) Israel $0.245B 0.00
OptiNose (OPTN) United States $0.213B 0.00
Xeris Pharmaceuticals (XERS) United States $0.201B 0.00
VAXART, INC (VXRT) United States $0.197B 0.00
PROFOUND MEDICL (PROF) Canada $0.196B 0.00
KalVista Pharmaceuticals (KALV) United States $0.194B 0.00
Taiwan Liposome (TLC) Taiwan $0.188B 0.00
Nature's Sunshine Products (NATR) United States $0.185B 24.33
IMV INC (IMV) Canada $0.184B 0.00
Jounce Therapeutics (JNCE) United States $0.184B 4.40
Matinas Biopharma Holdings (MTNB) United States $0.178B 0.00
Aquestive Therapeutics (AQST) United States $0.168B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.129B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.127B 0.00
Altimmune (ALT) United States $0.127B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.121B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.115B 0.00
Recro Pharma (REPH) United States $0.113B 0.00
Champions Oncology (CSBR) United States $0.109B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.101B 0.00
Sundial Growers (SNDL) Canada $0.094B 0.00
Heat Biologics (HTBX) United States $0.094B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.089B 0.00
CV Sciences (CVSI) United States $0.088B 0.00
Otonomy (OTIC) United States $0.081B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.078B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.077B 0.00
SCYNEXIS (SCYX) United States $0.076B 0.00
Hemispherx BioPharma (AIM) United States $0.073B 0.00
Onconova Therapeutics (ONTX) United States $0.068B 0.00
Nivalis Therapeutics (ALPN) United States $0.067B 0.00
Biomerica (BMRA) United States $0.064B 0.00
Iterum Therapeutics (ITRM) Ireland $0.062B 0.00
Aclaris Therapeutics (ACRS) United States $0.056B 0.00
RENEURON GP (RNUGF) United Kingdom $0.056B 0.00
MediWound (MDWD) Israel $0.054B 0.00
Infinity Pharmaceuticals (INFI) United States $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.050B 29.82
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.050B 0.00
Natural Alternatives (NAII) United States $0.049B 0.00
IsoRay (ISR) United States $0.048B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.048B 102.00
GTx (ONCT) United States $0.047B 0.00
Lipocine (LPCN) United States $0.044B 0.00
Forward Pharma (FWP) Denmark $0.041B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.040B 0.00
PolarityTE (PTE) United States $0.039B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.036B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.036B 0.00
ElectroCore (ECOR) United States $0.035B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.035B 0.00
Neos Therapeutics (NEOS) United States $0.034B 0.00
Mannatechorporated (MTEX) United States $0.031B 5.90
AgeX Therapeutics (AGE) United States $0.028B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.025B 0.00
Jaguar Animal Health (JAGX) United States $0.025B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.024B 0.00
India Globalization Capital (IGC) United States $0.024B 0.00
Bio-Path Holdings (BPTH) United States $0.020B 0.00
ProPhase Labs (PRPH) United States $0.020B 0.00
Novan (NOVN) United States $0.019B 0.00
Can-Fite Biopharma (CANF) Israel $0.018B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.016B 0.00
Regulus Therapeutics (RGLS) United States $0.015B 0.00
Flex Pharma (SLRX) United States $0.014B 0.00
Cyanotech (CYAN) United States $0.012B 0.00
China SXT Pharmaceuticals (SXTC) China $0.012B 0.00
Shineco (TYHT) China $0.012B 0.00
Vical (BBI) United States $0.011B 0.00
RXi Pharmaceuticals (PHIO) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.007B 0.00
Midatech Pharma (MTP) United Kingdom $0.007B 0.00
HANCOCK JAFFE (HJLI) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Addex Therapeutics (ADXN) Switzerland $0.000B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00